BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8140274)

  • 41. Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure.
    Liu C; Chen Y; Kang Y; Ni Z; Xiu H; Guan J; Liu K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):203-9. PubMed ID: 21737535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal mechanisms of human alpha-atrial natriuretic peptide in man.
    Brown J; Corr L
    J Physiol; 1987 Jun; 387():31-46. PubMed ID: 2958623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal interstitial cGMP mediates natriuresis by direct tubule mechanism.
    Jin XH; Siragy HM; Carey RM
    Hypertension; 2001 Sep; 38(3):309-16. PubMed ID: 11566896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction among atrial natriuretic factor (ANF), vasopressin, and renal nerves in terms of renal responses in rats.
    Patel KP
    Life Sci; 1991; 48(3):261-7. PubMed ID: 1825126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on potential involvement of protein kinase C in glomerular insensitivity to atrial natriuretic factor on low sodium intake.
    Kalinowski L; Szczepańska-Konkel M; Jankowski M; Angielski S
    Med Sci Monit; 2001; 7(4):628-34. PubMed ID: 11433187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
    Cusson JR; Hamet P; Gutkowska J; Kuchel O; Genest J; Cantin M; Larochelle P
    J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The renal and vascular effects of central angiotensin II and atrial natriuretic factor in the anaesthetized rat.
    Al-Barazanji KA; Balment RJ
    J Physiol; 1990 Apr; 423():485-93. PubMed ID: 2143782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
    Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Centrally administered atrial natriuretic factor increases renal water excretion.
    Lee J; Feng JQ; Malvin RL; Huang BS; Grekin RJ
    Am J Physiol; 1987 Jun; 252(6 Pt 2):F1011-5. PubMed ID: 2954469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of acute renal denervation and ANF on renal function in adult spontaneously hypertensive rats.
    Pollock DM; Arendshorst WJ
    Am J Physiol; 1991 Oct; 261(4 Pt 2):R835-41. PubMed ID: 1833989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist, blocks ANP-induced renal responses through a specific interaction with guanylyl cyclase-linked receptors.
    Morishita Y; Sano T; Kase H; Yamada K; Inagami T; Matsuda Y
    Eur J Pharmacol; 1992 Mar; 225(3):203-7. PubMed ID: 1355444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of the ANF analog A68828 in cisplatin-induced acute renal failure.
    Pollock DM; Holst M; Opgenorth TJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1179-83. PubMed ID: 1828504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist.
    Sakamoto K; Kikkawa R; Haneda M; Shigeta Y
    Diabetologia; 1995 May; 38(5):536-42. PubMed ID: 7489835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atrial peptide and cGMP effects on NaCl transport in inner medullary collecting duct.
    Rocha AS; Kudo LH
    Am J Physiol; 1990 Aug; 259(2 Pt 2):F258-68. PubMed ID: 2167016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of bradykinin B2 receptor antagonist and indomethacin on natriuretic and hypotensive responses to atrial natriuretic factor.
    Veress AT; Chong CK; Honrath U; Sonnenberg H
    Can J Physiol Pharmacol; 1994 Dec; 72(12):1561-6. PubMed ID: 7736348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renal and endocrine effects of physiological variations of atrial natriuretic factor in normal humans.
    Bruun NE; Skøtt P; Giese J
    Am J Physiol; 1991 Jan; 260(1 Pt 2):R217-24. PubMed ID: 1847023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation by low sodium intake of glomerular response to cicletanine and atrial natriuretic factor.
    Kalinowski L; Szczepanska-Konkel M; Jankowski M; Angielski S
    Br J Pharmacol; 1997 Jun; 121(4):635-42. PubMed ID: 9208128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of synthetic atrial natriuretic factor in the isolated perfused rat kidney.
    Murray RD; Itoh S; Inagami T; Misono K; Seto S; Scicli AG; Carretero OA
    Am J Physiol; 1985 Oct; 249(4 Pt 2):F603-9. PubMed ID: 2931997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal effects of atrial natriuretic factor in primate.
    Bourgoignie JJ; Gavellas G; Hwang KH
    Am J Physiol; 1986 Dec; 251(6 Pt 2):F1049-54. PubMed ID: 2947474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal effects of atrial natriuretic factor are independent of dopamine1 receptors.
    Murphy MB; Bass AS; Goldberg LI
    Am J Physiol; 1988 Sep; 255(3 Pt 2):F494-9. PubMed ID: 2970800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.